Skin Irritation Clinical Trial
Official title:
100 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Semi-Occlusive Patch)
NCT number | NCT01892410 |
Other study ID # | GLI.04.SRE.US10235 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 2012 |
Verified date | June 2013 |
Source | Galderma R&D |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Determine if Cetaphil Restoraderm Skin Restoring Body Wash proves to be a contact sensitizer or irritant in certain individuals.
Status | Completed |
Enrollment | 100 |
Est. completion date | |
Est. primary completion date | January 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Not currently under a doctor's care - Free of dermatological or systemic disorder which would interfere with the results - Free of any acute or chronic disease - Will complete a preliminary medical history form and are in general good health - Can read, understand, and sign informed consent Exclusion Criteria: - Under 18 years old - Currently under doctor's care - Currently taking any medication - History of acute or chronic disease - Diagnosed with chronic skin allergies - Pregnant or lactating |
Country | Name | City | State |
---|---|---|---|
United States | AMA Laboratories, Inc. | New City | New York |
Lead Sponsor | Collaborator |
---|---|
Galderma R&D |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Area of irritation measured to determine sensitivity | 9 consecutive 24hr exposures for every Monday, Wednesday, and Friday for 3 consecutive weeks | 3 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01806831 -
Efficacy and Safety of Biocellulose Sheet Containing Anti-hyperpigmentation Agent ("Biocellulose Mask", "Farhorm®") in Patients Receiving Laser Treatment
|
N/A | |
Completed |
NCT02297841 -
Repeated Insult Patch Test of Personal Lubricants
|
N/A | |
Completed |
NCT02968446 -
Effect of Vitamin D After Application With Valchlor
|
Early Phase 1 | |
Completed |
NCT03397862 -
A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System
|
Phase 1 | |
Unknown status |
NCT01821274 -
A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test Design
|
Phase 1 | |
Completed |
NCT01892657 -
Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test
|
Phase 4 | |
Withdrawn |
NCT02400320 -
Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol
|
Phase 4 | |
Not yet recruiting |
NCT02645110 -
Evaluation of Effectiveness and Mildness of Whole-natural Hand-wash Formulations
|
N/A | |
Completed |
NCT01888887 -
Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser
|
N/A | |
Completed |
NCT01887860 -
Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50
|
N/A | |
Completed |
NCT01887808 -
Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Dermacontrol Oil Control Moisturizer SPF 30
|
N/A | |
Completed |
NCT01892423 -
Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion
|
N/A |